BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7635968)

  • 21. Synergistic growth stimulation of mouse fibroblasts by tumor-derived adhesion factor with insulin-like growth factors and insulin.
    Akaogi K; Sato J; Okabe Y; Sakamoto Y; Yasumitsu H; Miyazaki K
    Cell Growth Differ; 1996 Dec; 7(12):1671-7. PubMed ID: 8959335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-rich residual bodies and cathepsin D in the human uterus: ultrastructural and quantitative comparison between normal myometrium and leiomyoma.
    Yamazaki K; Yakumaru K; Eyden BP
    J Submicrosc Cytol Pathol; 1993 Jul; 25(3):437-47. PubMed ID: 8402543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myosin heavy chain isoform expression in human myometrium: presence of an embryonic nonmuscle isoform in leiomyomas and in cultured cells.
    Cavaillé F; Fournier T; Dallot E; Dhellemes C; Ferré F
    Cell Motil Cytoskeleton; 1995; 30(3):183-93. PubMed ID: 7758135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma.
    Senturk LM; Sozen I; Gutierrez L; Arici A
    Am J Obstet Gynecol; 2001 Mar; 184(4):559-66. PubMed ID: 11262453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
    Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
    Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
    Luo X; Levens E; Williams RS; Chegini N
    Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human ESP1/CRP2, a member of the LIM domain protein family: characterization of the cDNA and assignment of the gene locus to chromosome 14q32.3.
    Karim MA; Ohta K; Egashira M; Jinno Y; Niikawa N; Matsuda I; Indo Y
    Genomics; 1996 Jan; 31(2):167-76. PubMed ID: 8824798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
    Bader AG; Schneider ML; Bister K; Hartl M
    Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and characterization of human lung fibroblast motility-stimulating factor for human soft tissue sarcoma cells: identification as an NH2-terminal fragment of human fibronectin.
    Hu M; Pollock RE; Nicolson GL
    Cancer Res; 1997 Aug; 57(16):3577-84. PubMed ID: 9270031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma.
    Arici A; Sozen I
    Am J Obstet Gynecol; 2003 Jan; 188(1):76-83. PubMed ID: 12548199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-sepharose binding growth factors in peritoneal fluid of women with endometriosis.
    Koutsilieris M; Niklinski W; Frenette G; Lemay A
    Fertil Steril; 1993 Jan; 59(1):93-7. PubMed ID: 8419230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of human uterus-derived growth substances.
    Koutsilieris M; Michaud J
    In Vivo; 1990; 4(3):161-5. PubMed ID: 2133257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy.
    Kawaguchi K; Fujii S; Konishi I; Iwai T; Nanbu Y; Nonogaki H; Ishikawa Y; Mori T
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(4):309-15. PubMed ID: 1949613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of genes with higher expression in human uterine leiomyomas than in the corresponding myometrium.
    Wu X; Blanck A; Norstedt G; Sahlin L; Flores-Morales A
    Mol Hum Reprod; 2002 Mar; 8(3):246-54. PubMed ID: 11870232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uterus-derived growth substances: possible implications for human uterus physiology and pathophysiology (review). The Group for Gynecological Investigation.
    Koutsilieris M
    In Vivo; 1990; 4(1):45-8. PubMed ID: 2103841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-Met expression pattern in uterine leiomyoma.
    Boynukalin FK; Comunoglu C; Türkmen I; Kuzey GM; Güler OT; Baykal C
    Clin Exp Obstet Gynecol; 2014; 41(3):254-7. PubMed ID: 24992771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of a proliferation inhibitor factor from uterine myomatosis fibroblasts.
    Sánchez-Sánchez L; Chávez MA; Manjarrez A; López R; Zenteno E; Weiss-Steider B
    Prep Biochem Biotechnol; 1999 Feb; 29(1):23-33. PubMed ID: 10069430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smooth muscle differentiation in human myometrium and uterine leiomyoma.
    Draeger A; Graf AH; Staudach A; North AJ; Small JV
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(1):21-7. PubMed ID: 8401813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of menstrual cycle on protein expression in human uterine leiomyomas.
    Shek YH; Stastny JJ; Fosslien E
    Obstet Gynecol; 1987 Jul; 70(1):128-33. PubMed ID: 3601261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidermal growth factor (EGF) in uterine leiomyoma during tumour growth].
    Wolańska M; Jaworski S
    Ginekol Pol; 2005 Aug; 76(8):643-7. PubMed ID: 16363371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.